Onkos Surgical Acquires the Juvenile Tumour System (JTS) from Stryker
June 13, 2022
Onkos Surgical entered into a definitive agreement to acquire the Juvenile Tumour System (JTS) extendible prosthesis from Stryker. The device enables non‑invasive implant lengthening for pediatric bone cancer and limb reconstruction cases, and the acquisition expands Onkos's musculoskeletal oncology product portfolio and clinical capabilities.
- Buyers
- Onkos Surgical
- Targets
- Juvenile Tumour System (JTS) extendible prosthesis
- Sellers
- Stryker
- Industry
- Medical Devices
- Location
- Michigan, United States
- Transaction Type
- Divestiture
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.